drugset / Trial / NCT03273881

Intrapartum Glucose and Insulin Compared to Glucose Alone in Diabetic Women

NCT03273881

RandomizedParallel-groupOpen-labelPrevention

Summary

This study aims to examine the effect of intrapartum treatment of diabetic women with combined glucose and constant insulin infusion compared to glucose alone on the incidence of neonatal hypoglycemia. Pregnant women with diabetes in pregnancy will be randomly divided during labor to 2 groups: group 1, will receive intravenous glucose with constant insulin infusion; group 2 will receive intravenous glucose alone. The primary outcome is the incidence of neonatal hypoglycemia.

Timeline

Start
2017-10-31
Primary completion
2023-12-31
Completion
2023-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic 8 iu Intravenous
Comparator Glucose Unknown 5 % Intravenous